FDA Approved: BELRAPZO — Supplemental Application (Eagle Pharmaceuticals, Inc)

View source ↗

Summary

The FDA approved a supplemental application for Belrapzo (bendamustine hydrochloride) submitted by Eagle Pharmaceuticals, Inc. The action updates the regulatory…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Follicular Lymphoma
• Mantle Cell Lymphoma
• Non-hodgkin Lymphoma
• Small Lymphocytic Lymphoma

Drugs mentioned

• BELRAPZO (BENDAMUSTINE HYDROCHLORIDE)

Snippet

SUPPL AP for BELRAPZO (BENDAMUSTINE HYDROCHLORIDE)